Postoperative topical antimicrobial use

Dermatitis

Volumn 19, Issue 4, 2008, Pages 181-189

  Sheth, Vaneeta M ^a   Weitzul, Sarah ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BACITRACIN; CETOSTEARYLIC ALCOHOL; CHLORHEXIDINE; FUSIDIC ACID; GENTAMICIN; LANOLIN; MACROGOL; METHYL PARABEN; MINERAL OIL; NEBACETIN; NEOMYCIN; NEOSPORIN; POLYMYXIN B; POLYSPORIN; POVIDONE IODINE; PROPYL PARABEN; PSEUDOMONIC ACID; WHITE PETROLATUM;

ANAPHYLAXIS; ANTIBIOTIC PROPHYLAXIS; CREAM; EMULSION; ENTEROBACTER; EPITHELIZATION; ESCHERICHIA COLI; EUROPE; EXPERIMENTAL MOUSE; FIBROBLAST; HUMAN; INFECTION CONTROL; KERATINOCYTE; KLEBSIELLA; NONHUMAN; NORTH AMERICA; PAENIBACILLUS POLYMYXA; PATCH TEST; POSTOPERATIVE CARE; POSTOPERATIVE INFECTION; POSTOPERATIVE PERIOD; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROTEUS MIRABILIS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS FLUORESCENS; REVIEW; SERRATIA MARCESCENS; SKIN ALLERGY; SKIN SURGERY; STAPHYLOCOCCUS INFECTION; STREPTOCOCCUS INFECTION; STREPTOMYCES FRADIAE; WOUND CARE; WOUND HEALING; WOUND INFECTION;

ANIMALS; ANTI-BACTERIAL AGENTS; BACITRACIN; DERMATITIS, ALLERGIC CONTACT; HUMANS; INCIDENCE; MUPIROCIN; NEOMYCIN; PATCH TESTS; POLYMYXIN B; POSTOPERATIVE CARE; PRACTICE GUIDELINES AS TOPIC; SKIN; SURGICAL WOUND INFECTION;

EID: 51149121685     PISSN: 17103568     EISSN: None     Source Type: Journal    
DOI: 10.2310/6620.2008.07094     Document Type: Review

References (53)

1. Fleischer AB Jr, Feldman SR, White RE, et al. Procedures for skin diseases performed by physicians in 1993 and 1994: analysis of data from the National Ambulatory Medical Care Survey. J Am Acad Dermatol 1997;37(5 Pt 1):719-24.
2. Neville JA, Housman TS, Letsinger JA, et al. Increase in procedures performed at dermatology office visits from 1995 to 2001. Dermatol Surg 2005;31:160-2.
3. American Society for Dermatologic Surgeons. 2005 Procedure survey: dermasurgery trends and statistics. Available at: http://www.asds.net/Media/ Archives/ASDS2005StatsReport.pdf (accessed August 8, 2007).
4. Centers for Disease Control and Prevention statistics on skin cancer. Available at: http://www.cdc.gov/cancer/skin/statistics/ (accessed August 8, 2007).
5. Goodman N, Scales JT, Towers AG. Development and evaluation of a porous surgical dressing. Br Med J 1956;12:962-8.
6. Aindow D, Butcher M. Films or fabrics: is it time to re-appraise postoperative dressings? Br J Nurs 2005;14:S15-6, S18, S20.
7. Kannon GA, Garrett AB. Moist wound healing with occlusive dressings. A clinical review. Dermatol Surg 1995;21:583-90.
8. Eaglstein WH. Occlusive dressings. J Dermatol Surg Oncol 1993;19: 716-20.
9. Telfer NR, Moy RL. Wound care after office procedures. J Dermatol Surg Oncol 1993;19:722-31.
10. Dahlberg AE, Horodyski F, Keller P. Interaction of neomycin with ribosomes and ribosomal ribonucleic acid. Antimicrob Agents Chemother 1978;13:331-9.
11. Clark JM, Chang AY. Inhibitors of the transfer of amino acids from aminoacyl soluble ribonucleic acid to proteins. J Biol Chem 1965; 240:4734-9.
12. Spann CT, Taylor SC, Weinberg JM. Topical antimicrobial agents in dermatology. Clin Dermatol 2003;21:70-7.
13. Spann CT, Taylor SC, Weinberg JM. Topical antimicrobial agents in dermatology. Dis Mon 2004;50:407-21.
14. Spann CT, Tutrone WD, Weinberg JM, et al. Topical antibacterial agents for wound care: a primer. Dermatol Surg 2003;29:620-6.
15. Kaye ET. Topical antibacterial agents. Infect Dis Clin North Am 2000;14:321-39.
16. Stone KJ, Strominger JL. Inhibition of sterol biosynthesis by bacitracin. Proc Natl Acad Sci U S A 1972;69:1287-9.
17. Hughes J, Mellows G. Inhibition of isoleucyl-transfer ribonucleic acid synthetase in Escherichia coli by pseudomonic acid. Biochem J 1978;176:305-18.
18. Bactroban Glaxo Smith Kline prescribing information. Available at: http://us.gsk.com/products/assets/us_bactroban_ointment.pdf (accessed on August 8, 2007).
19. Fusidic acid prescribing information. Available at: http://www.med-safe. govt.nz/Profs/Datasheet/f/Fucidintabinjsus.htm (accessed on October 13, 2007).
20. O'Neill AJ, Larsen AR, Skov R, et al. Characterization of the epidemic European fusidic acid-resistant impetigo clone of Staphylococcus aureus. J Clin Microbiol 2007;45:1505-10.
21. Muller NF, Dessing RP. European drug index. London, England: CRC Press 1997. 520.
22. Binnick AN, Clendenning WE. Bacitracin contact dermatitis. Contact Dermatitis 1978;4:180-1.
23. Pirila V, Forstrom L, Rouhunkoski S. Twelve years of sensitization to neomycin in Finland. Report of 1760 cases of sensitivity to neomycin and-or bacitracin. Acta Derm Venereol 1967;47: 419-25.
24. Leyden JJ, Kligman AM. Contact dermatitis to neomycin sulfate. IAMA 1979;242:1276-8.
25. Pratt MD, Belsito DV, DeLeo VA, et al. North American Contact Dermatitis Group patch-test results, 2001-2002 study period. Dermatitis 2004;15:176-83.
26. Wetter DA, Davis MDP, Yiannias JA, et al. Patch test results from the Mayo Clinic Contact Dermatitis Group, 1998-2000. J Am Acad Dermatol 2005;53:416-21.
27. Menezes de Padua CA, Schnuch A, Lessman H, et al. Contact allergy to neomycin sulfate: results of a multifactorial analysis. Pharmacoepidemiol Drug Safety 2005;14:725-33.
28. Menezes de Padua CA, Uter W, Schnuch A. Contact allergy to topical drugs: prevalence in clinical setting and estimation of frequency at the population level. Pharmacoepidemiol Drug Safety 2007;16:377-84.
29. Morris SD, Rycroft RJG, White IR, et al. Comparative frequency of patch test reactions to topical antibiotics. Br J Dermatol 2002;146:1047-51.
30. Grandinetti PJ, Fowler JF. Simultaneous contact allergy to neomycin, bacitracin, and polymyxin. J Am Acad Dermatol 1990;23(4 Pt 1):646-7.
31. Goh CL. Contact sensitivity to topical antimicrobials. Contact Dermatitis 1989;21:166-71.
32. Cameron J, Wilson C, Powell S, et al. Contact dermatitis in leg ulcer patients. Ostomy Wound Manage 1992;388:10-1.
33. Wilson CL, Cameron J, Powell SM, et al. High incidence of contact dermatitis in leg-ulcer patients - implications for management. Clin Exp Dermatol 1991;16:250-3.
34. Whitaker DC, Grande DJ, Johnson SS. Wound infection rate in dermatologic surgery. J Dermatol Surg Oncol 1998;14:525-8.
35. Dixon AJ, Dixon MP, Askew DA, et al. Prospective study of wound infections in dermatologic surgery in the absence of prophylactic antibiotics. Dermatol Surg 2006;32:819-27.
36. Rogues AM, Lasheras A, Amici JM, et al. Infection control practices and infectious complications in dermatologic surgery. J Hosp Infect 2007;65:258-63.
37. Amici JM, Rogues AM, Lasheras A, et al. A prospective study of the incidence of complications associated with dermatological surgery. Br J Dermatol 2005;153:967-71.
38. Cook JL, Perone JB. A prospective evaluation of the incidence of complications associated with Mohs micrographic surgery. Arch Dermatol 2003;139:143-52.
39. Vale MA, Connolly A, Epstein AM, et al. Bacitracin-induced anaphylaxis. Arch Dermatol 1978;114:800.
40. Schechter JF, Wilkinson RD, Del Carpio J. Anaphylaxis following the use of bacitracin ointment. Report of a case and review of the literature. Arch Dermatol 1984;120:909-11.
41. Saryan JA, Dammin TC, Bouras AE. Anaphylaxis to topical bacitracin zinc ointment. Am J Emerg Med 1998;16:512-3.
42. Gette MT, Marks JG, Maloney ME. Frequency of postoperative allergic contact dermatitis to topical antibiotics. Arch Dermatol 1992;128:365-7.
43. Smack DP, Harrington AC, Dunn C, et al. Infection and allergy incidence in ambulatory surgery patients using white petrolatum vs. bacitracin ointment. A randomized controlled trial. JAMA 1996; 276:972-7.
44. Dixon AJ, Dixon MP, Dixon JB. Randomized clinical trial of the effect of applying ointment to surgical wounds before occlusive dressing. Br J Surg 2006;93:937-13.
45. Mack RM, Cantrell JR. Quantitative studies of the bacterial flora of open skin wounds: the effect of topical antibiotics. Ann Surg 1967; 166:886-95.
46. Marks J, Harding KG, Hughes LE. Staphylococcal infection of open granulating wounds. Br J Surg 1987;74:95-7.
47. Leyden JJ, Bartelt NM. Comparison of topical antibiotic ointments, a wound protectant, and antiseptics for the treatment of human blister wounds contaminated with Staphylococcus aureus. J Fam Pract 1987;24:601-4.
48. Davis SC, Cazzaniga AL, Eaglstein WH, et al. Over-the-counter topical antimicrobials: effective treatments? Arch Dermatol Res 2005;297:190-5.
49. Watcher MA, Wheeland RG. The role of topical agents in the healing of full-thickness wounds. J Dermatol Surg Oncol 1989;15: 1188-95.
50. Mertz PM, Ovington LG. Wound healing microbiology. Dermatol Clin 1993;11:739-47.
51. Jacob SE, James WD. Bacitracin after clean surgical procedures may be risky. J Am Acad Dermatol 2004;51:1036.
52. Brown CD, Zitelli JA. A review of topical agents for wounds and methods of wounding: guidelines for wound management. J Dermatol Surg Oncol 1993;19:732-7.
53. Sood A, Taylor J. Bacitracin: allergen of the year. Am J Contact Dermat 2003;14:3-4.